MAPT and Alzheimer disease: Thus, we could compare the changes in amyloid/tau in the brains of wild-type and sod2−/− mice treated with low and high doses of antioxidant (Figure 1) in order to test the hypothesis that oxidative stress from mitochondrial dysfunction promotes AD-like pathology.